Disaster preparedness, pediatric considerations in primary blast injury, chemical, and biological terrorism

doi:10.5492/wjccm.v3.i1.15

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7273)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-5) series.

Item

Count

PDF

497

WORD

324

HTML

4377

Tables (1-5)

195

Sum=5393

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1038

Download

842

Sum=1880

Feb 4, 2014 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Critical Care Medicine

ISSN

2220-3141

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Crit Care Med. Feb 4, 2014; 3(1): 15-23
Published online Feb 4, 2014. doi: 10.5492/wjccm.v3.i1.15

Table 3 Guidelines for the use of Mark I kits in pediatric patients

Pediatric patients	Mark I kits
3-7 yr (approximately 13-25 kg)	One Mark I kit as maximum dose
8-14 yr (approximately 26-50 kg)	Two Mark I kits as maximum dose
> 14 yr (approximately > 51 kg)	Three Mark I kits as maximum dose

Mark I kit: 2 mg atropine and 600 mg 2-PAM; PAM: Pralidoxime.

Citation: Hamele M, Poss WB, Sweney J. Disaster preparedness, pediatric considerations in primary blast injury, chemical, and biological terrorism. World J Crit Care Med 2014; 3(1): 15-23
URL: https://www.wjgnet.com/2220-3141/full/v3/i1/15.htm
DOI: https://dx.doi.org/10.5492/wjccm.v3.i1.15